Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.
1M | 3M | 6M | 1Y p.a. | 2Y p.a. | 3Y p.a. | 5Y p.a. | 10Y p.a. | |
Total return | 9.42% | 7.79% | 10.48% | -4.56% | 4.31% | 1.93% | 5.07% | -% |
Growth return | 9.42% | 7.79% | 10.48% | -4.56% | 4.31% | 1.93% | 5.07% | -% |
Income return | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -% |
Market index (S&P/ASX 200 TR AUD)
|
||||||||
Total return | 3.1% | 7.03% | 11.65% | 14.74% | 14.82% | 13.04% | 12.32% | 9.87% |
Type | Description |
LifeplanNG Advc Maple-Brown Abbott Imputation Open | |
Closed | |
Lifeplan Australia Friendly Society Ltd | |
LIF0136AU | |
Equity Australia Large Value | |
![]() ![]() ![]() ![]() |
|
Investment Fund | |
1 May 2012 | |
$0.76 million (as at 30 Nov 2020) | |
$1.633 (as at 14 Dec 2020) | |
$1.633 (as at 14 Dec 2020) | |
Finalised |
Type | Description |
Minimum initial investment | $1,000.00 |
Minimum additional investments | $100.00 |
Minimum redemption amount | $500.00 |
Holding (as at 31 Jan 2025) | Type | % of Portfolio |
ANZ Group Holdings Ltd | Equity | 7.66% |
Login now to view the complete list of holdings. |
The objective of the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund is Aims to outperform(before fees) the S&P/ASX 200 Index (total returns) over rolling four-year periods.
The strategy of the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund is The underlying portfolio invests directly in Australian listed equities, including REITs, or directly via the Maple-Brown Abbott Small Companies Trust.
The APIR code of the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund is LIF0136AU.
LifeplanNG Advc Maple-Brown Abbott Imputation Open’s total return last month was 9.42%. This was made up of a growth return of 9.42% and an income return of 0%. These returns were calculated as at 30 Nov 2020.
LifeplanNG Advc Maple-Brown Abbott Imputation Open’s total return for the last three months was 7.79%. This was made up of a growth return of 7.79% and an income return of 0%%. These returns were calculated as at 30 Nov 2020.
LifeplanNG Advc Maple-Brown Abbott Imputation Open’s one-year total return is -4.56%. This was made up of a growth return of -4.56% and an income return of 0%. These returns were calculated as at 30 Nov 2020.
LifeplanNG Advc Maple-Brown Abbott Imputation Open’s one-year total return is 1.93%. This was made up of a growth return of 1.93% and an income return of 0%. These returns were calculated as at 30 Nov 2020.
The asset allocation of the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund is :
The Responsible Entity for the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund is Lifeplan Australia Friendly Society Ltd.
The LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund belongs to the Equity Australia Large Value sector/asset class.
As at 30 Nov 2020, the size of the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund was $0.76 million.
The LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund has an inception date of 1 May 2012.
The current entry price of the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund is $1.633 per unit and the current exit price is $1.633 per unit (as at 14 Dec 2020).
The current exit price of the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund is $1.633 per unit and the current entry price is $1.633 per unit (as at 14 Dec 2020).
The minimum initial investment amount for the LifeplanNG Advc Maple-Brown Abbott Imputation Open managed fund is $1,000. Minimum additional investment is $100.
Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.